Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Radiation Injuries, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT05465031 2025-03-14

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Phase 4 Recruiting

600 enrolled

Breast

Breast Diseases, Breast Neoplasms, Heart Failure, Neoplasms, Second Primary, Cardiotoxicity

NCT03934905 2024-11-20

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Phase 1/2 Recruiting

70 enrolled

Cardiotoxicity

NCT05703126 2024-11-05

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

Phase NA Recruiting

100 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Cardiotoxicity

NCT06622954 2024-10-02

PROTECT-COR

Phase NA Recruiting

32 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT05467111 2024-04-11

CardioProtEx

Phase NA Recruiting

40 enrolled

Breast

Breast Neoplasms, Motor Activity, Cardiotoxicity

NCT06340516 2024-04-01

NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity

Phase NA Recruiting

700 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT06270667 2024-03-22

LYMfit

Phase NA Recruiting

280 enrolled

Lymphoid

Cardiovascular Diseases, Lymphoma, Motor Activity, Cardiotoxicity

NCT06214195 2024-01-19

START

Phase 3 Recruiting

276 enrolled

Cardiotoxicity

NCT05732051 2023-03-17

NARNIA

Phase 2 Recruiting

60 enrolled

Breast

Breast Neoplasms, Heart Failure, Cardiotoxicity

NCT04822077 2021-03-30

PROTHYM

Phase NA Recruiting

40 enrolled

Thoracic

Thymoma, Thymus Neoplasms, Cardiotoxicity

Clinical Trials

CMR-Onko

STOP-MED CTRCD

BREATHS

BE-FITTER

HO170DLBCL

A Study of Blood Pressure Control During Cancer Treatment

HIMALAYAS

EMPACT

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

TRUST-ACE

HER2BIC

CARTIER

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

PROTECT-COR

CardioProtEx

NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity

LYMfit

START

NARNIA

PROTHYM